Frequent overexpression of CADM1/IGSF4 in lung adenocarcinoma
Yuka Kitamura1, Gene Kurosawa, Miho Tanaka
1Department of Surgery, School of Medicine, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Abstract:
We reported comprehensive screening for antigens (Ags) overexpressed on various carcinomas via isolation of human monoclonal antibodies (mAbs) that may be therapeutic in a previous paper (Proc. Natl. Acad. Sci. USA 105, 7287-7292, 2008). Twenty-one distinct Ags highly expressed on several carcinomas were identified and 356 mAbs with unique sequences turned out to bind to one of the 21 Ags. Among them CADM1/IGSF4 which had been originally referred to as tumor suppressor lung cancer 1 (TSLC1) was included. Therefore we examined the expression of CADM1 in lung cancers in this study. Eight different anti CADM1 mAbs were used for immunohistochemical analysis of 29 fresh lung cancer specimens. Staining patterns were categorized to six groups based on the extent of positive staining and the localization of stained portions. While overexpression of CADM1 was observed on the cell surface of adenocarcinomas at a high frequency, around 60%, positive stainings were rarely observed on that of other lung carcinomas including squamous cell carcinomas. Moreover, some clones among the eight mAbs gave different staining patterns from those by the other clones against the same fresh specimen, suggesting presence of variant forms of CADM1 differentiated by mAbs.
Insights
This study investigated CADM1 expression in lung cancer, finding it frequently overexpressed on adenocarcinoma cell surfaces. This suggests CADM1 may be a valuable biomarker for specific lung carcinoma subtypes.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Previous research identified 21 overexpressed antigens (Ags) on carcinomas using monoclonal antibodies (mAbs).
- CADM1/IGSF4, also known as tumor suppressor lung cancer 1 (TSLC1), was among the identified Ags.
Purpose of the Study:
- To investigate the expression patterns of CADM1 in various lung carcinoma types.
- To determine the potential of CADM1 as a diagnostic or therapeutic target in lung cancer.
Main Methods:
- Immunohistochemical analysis of 29 fresh lung cancer specimens using eight distinct anti-CADM1 mAbs.
- Categorization of staining patterns based on extent and localization of positive staining.
Main Results:
- CADM1 was overexpressed on the cell surface of lung adenocarcinomas in approximately 60% of cases.
- Positive CADM1 staining was infrequent in other lung carcinoma types, including squamous cell carcinomas.
- Different anti-CADM1 mAb clones exhibited varying staining patterns on the same specimens, indicating potential CADM1 variants.
Conclusions:
- CADM1 is frequently overexpressed in lung adenocarcinomas, suggesting its potential as a subtype-specific biomarker.
- The differential expression of CADM1 across lung cancer types warrants further investigation for targeted therapies.
- The observed mAb-dependent variations in CADM1 staining suggest the existence of distinct CADM1 isoforms or conformational states.
Related Concept Videos
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Structure of Cadherins
Abnormal Proliferation
